SCHEMBL28020967

SCHEMBL28020967

N#Cc1ccccc1OCBr

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
GAA P10253 2/20 0.49
MAPK1 P28482 2/20 0.47
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
POLB P06746 1/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
ADRA2B P18089 1/20 0.45
MAOA P21397 1/20 0.45
HTR2B P41595 1/20 0.45
KDM4E B2RXH2 2/20 0.43
TP53 P04637 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NOTUM Q6P988 1/20 0.41
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11748737 0.84 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2GAAMAPK1HPGD
SCHEMBL1942660 0.82 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2GAAMAPK1HPGD
SCHEMBL3081344 0.81 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2GAAMAPK1HPGD
SCHEMBL30826934 0.80 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2GAAMAPK1HPGD
SCHEMBL30283197 0.79 SMN1; SMN2 (0.51) ALDH1A1SMN1; SMN2GAAMAPK1HPGD
SCHEMBL5451 0.79 SMN1; SMN2 (0.51) ALDH1A1SMN1; SMN2GAAMAPK1HPGD
SCHEMBL6832323 0.79 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2GAAMAPK1HPGD
SCHEMBL17603410 0.79 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2GAAMAPK1HPGD
SCHEMBL536014 0.79 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2GAAMAPK1HPGD
SCHEMBL10375523 0.79 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2GAAMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311887-A Pyrazolo [1,5-a] pyrimidine radicals benzamide compound and they treatment medical conditions in purposes 溶酶体治疗股份有限公司 2019-02-05 CN disclosed
CN-103261165-B Glucagon receptor modulators PFIZER INC. (US) 2015-08-26 CN disclosed